Anti-BP230 Only Bullous Pemphigoid Constitutes a Distinct Disease Subgroup with Characteristic Serological and Clinical Features

Torben Ramcke; Vanessa Bolduan; Elisabeth Vicari; Kaan Yilmaz; Ines Bertlich; Stephanie Goletz; Swantje Mindorf; Jochen Hoffmann; Enno Schmidt; Alexander Enk; Eva Hadaschik

doi:10.1016/j.jid.2022.05.1084

Anti-BP230 Only Bullous Pemphigoid Constitutes a Distinct Disease Subgroup with Characteristic Serological and Clinical Features

Torben Ramcke^*, Vanessa Bolduan, Elisabeth Vicari, Kaan Yilmaz, Ines Bertlich, Stephanie Goletz, Swantje Mindorf, Jochen Hoffmann, Enno Schmidt, Alexander Enk, Eva Hadaschik

^*Corresponding author for this work

Institute of Experimental Dermatology

5 Citations (Scopus)

Original language	English
Journal	Journal of Investigative Dermatology
Volume	142
Issue number	11
Pages (from-to)	3110-3113.e8
ISSN	0022-202X
DOIs	https://doi.org/10.1016/j.jid.2022.05.1084
Publication status	Published - 11.2022

Funding

We thank Lena Beideck for the excellent technical help. The study was supported by grants from the Deutsche Forschungsgemeinschaft, Germany ( DFG , German Research Foundation, Germany ) TRR156/2 – 246807620 (to EH and AE) as well as structural funding from the Schleswig-Holstein Excellence Cluster Precision Medicine in Chronic Inflammation ( DFG EXC 2167/1) and the CRU 303 Pemphigoid Diseases. The work was carried-out in Heidelberg, Baden-Württemberg, Germany.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)
Centers: Center for Research on Inflammation of the Skin (CRIS)

DFG Research Classification Scheme

2.21-05 Immunology
2.22-19 Dermatology

Access to Document

10.1016/j.jid.2022.05.1084

Cite this

Ramcke, T., Bolduan, V., Vicari, E., Yilmaz, K., Bertlich, I., Goletz, S., Mindorf, S., Hoffmann, J., Schmidt, E., Enk, A., & Hadaschik, E. (2022). Anti-BP230 Only Bullous Pemphigoid Constitutes a Distinct Disease Subgroup with Characteristic Serological and Clinical Features. Journal of Investigative Dermatology, 142(11), 3110-3113.e8. https://doi.org/10.1016/j.jid.2022.05.1084

@article{1fa73e69dc3447eb856da2b30bdcdcbd,

title = "Anti-BP230 Only Bullous Pemphigoid Constitutes a Distinct Disease Subgroup with Characteristic Serological and Clinical Features",

author = "Torben Ramcke and Vanessa Bolduan and Elisabeth Vicari and Kaan Yilmaz and Ines Bertlich and Stephanie Goletz and Swantje Mindorf and Jochen Hoffmann and Enno Schmidt and Alexander Enk and Eva Hadaschik",

note = "Funding Information: We thank Lena Beideck for the excellent technical help. The study was supported by grants from the Deutsche Forschungsgemeinschaft, Germany ( DFG , German Research Foundation, Germany ) TRR156/2 – 246807620 (to EH and AE) as well as structural funding from the Schleswig-Holstein Excellence Cluster Precision Medicine in Chronic Inflammation ( DFG EXC 2167/1) and the CRU 303 Pemphigoid Diseases. The work was carried-out in Heidelberg, Baden-W{\"u}rttemberg, Germany. ",

year = "2022",

month = nov,

doi = "10.1016/j.jid.2022.05.1084",

language = "English",

volume = "142",

pages = "3110--3113.e8",

journal = "Journal of Investigative Dermatology",

issn = "0022-202X",

publisher = "Elsevier B.V.",

number = "11",

}

Ramcke, T, Bolduan, V, Vicari, E, Yilmaz, K, Bertlich, I, Goletz, S, Mindorf, S, Hoffmann, J, Schmidt, E, Enk, A & Hadaschik, E 2022, 'Anti-BP230 Only Bullous Pemphigoid Constitutes a Distinct Disease Subgroup with Characteristic Serological and Clinical Features', Journal of Investigative Dermatology, vol. 142, no. 11, pp. 3110-3113.e8. https://doi.org/10.1016/j.jid.2022.05.1084

TY - JOUR

T1 - Anti-BP230 Only Bullous Pemphigoid Constitutes a Distinct Disease Subgroup with Characteristic Serological and Clinical Features

AU - Ramcke, Torben

AU - Bolduan, Vanessa

AU - Vicari, Elisabeth

AU - Yilmaz, Kaan

AU - Bertlich, Ines

AU - Goletz, Stephanie

AU - Mindorf, Swantje

AU - Hoffmann, Jochen

AU - Schmidt, Enno

AU - Enk, Alexander

AU - Hadaschik, Eva

N1 - Funding Information: We thank Lena Beideck for the excellent technical help. The study was supported by grants from the Deutsche Forschungsgemeinschaft, Germany ( DFG , German Research Foundation, Germany ) TRR156/2 – 246807620 (to EH and AE) as well as structural funding from the Schleswig-Holstein Excellence Cluster Precision Medicine in Chronic Inflammation ( DFG EXC 2167/1) and the CRU 303 Pemphigoid Diseases. The work was carried-out in Heidelberg, Baden-Württemberg, Germany.

PY - 2022/11

Y1 - 2022/11

UR - https://www.scopus.com/pages/publications/85134853689

U2 - 10.1016/j.jid.2022.05.1084

DO - 10.1016/j.jid.2022.05.1084

M3 - Journal articles

C2 - 35671826

AN - SCOPUS:85134853689

SN - 0022-202X

VL - 142

SP - 3110-3113.e8

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

IS - 11

ER -

Anti-BP230 Only Bullous Pemphigoid Constitutes a Distinct Disease Subgroup with Characteristic Serological and Clinical Features

Funding

UN SDGs

Research Areas and Centers

DFG Research Classification Scheme

Access to Document

Other files and links

Cite this